Read More Pharma Industry News Setback for diabetes innovation: FDA puts brakes on Novo Nordisk’s once-weekly insulin icodec Novo Nordisk announced that the US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL)… byPallavi MadhirajuJuly 11, 2024